Symantec Corporation Prospectus Supplement No. 2
 

     
Prospectus Supplement #2
(to prospectus dated February 19, 2002)
 
Filed pursuant to Rule 424(b)(3)
Registration No. 333-77072


SYMANTEC CORPORATION

3% Convertible Subordinated Notes Due November 1, 2006 and
Shares of Common Stock Issuable Upon Conversion of the Notes


     This prospectus supplement relates to the resale by the holders of our 3% convertible subordinated notes due November 1, 2006 and the shares of our common stock issuable upon the conversion of the notes. You should read this prospectus supplement in conjunction with the prospectus dated February 19, 2002, which is to be delivered with this prospectus supplement.

     The information in the table appearing under the heading “Selling Holders” in the prospectus is amended by the addition of the information appearing in the table below:

                                 
    Principal Amount of   Common Stock Owned           Common Stock Owned
    Notes Beneficially   Prior to the   Common   After Completion of
Name of Beneficial Owner
  Owned and Offered   Offering(1)(2)   Stock Offered(2)   the Offering

 
 
 
 
Aristeia International Limited
  $ 7,600,000       222,613       222,613        
Aristeia Partners, LP
    2,400,000       70,298       70,298        
City University of New York
    155,000       4,540       4,540        
Goldman Sachs and Company
    3,415,000       100,029       100,029        
Grady Hospital Foundation
    136,000       3,983       3,983        
New Orleans Firefighters Pension/ Relief Fund
    140,000       4,100       4,100        
New York Life Insurance Company
    1,490,000       43,643       43,643        
New York Life Insurance Company
    630,000       18,453       18,453        
Oppenheimer Convertible Securities Fund
    4,500,000       131,810       131,810        
TD Securities (USA) Inc.
    21,250,000       622,438       622,438        
Any other holders of notes or future transferee from any holder(3)(4)
    27,512,000       805,859       805,859        


(1)   Includes common stock into which the notes are convertible.
(2)   Assumes a conversion ratio of 29.2912 shares per $1,000 principal amount of notes and a cash payment in lieu of any fractional interest.
(3)   Information concerning other selling holders of notes will be set forth in prospectus supplements from time to time, if required.
(4)   Assumes that any other holders of notes or any future transferee from any holder does not beneficially own any common stock other than common stock into which the notes are convertible at the conversion rate of 29.2912 shares per $1,000 principal amount of notes.


     Investing in our common stock or the notes involves a high degree of risk. Please carefully consider the “Risk Factors” beginning on page 3 of the prospectus, as well as the “Risk Factors” section included in our recent reports filed with the Securities and Exchange Commission.

     NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE PROSPECTUS OR THIS PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this prospectus supplement is March 8, 2002.